Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents

Annals of Thoracic Surgery

Volumn 95, Issue 4, 2013, Pages 1297-1305

  Wu, Chuntao ^a   Camacho, Fabian T ^a   Zhao, Songyang ^b   Wechsler, Andrew S ^c   Culliford, Alfred T ^d   Lahey, Stephen J ^e   King III, Spencer B ^f   Walford, Gary ^g   Gold, Jeffrey P ^h   Smith, Craig R ⁱ   Jordan, Desmond ⁱ   Higgins, Robert S D ^j   Hannan, Edward L ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY AT ALBANY   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^f St Joseph's Health System   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h MEDICAL COLLEGE OF OHIO   (United States)

ⁱ Columbia University ^*  (United States)

^j OHIO STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CAROTID ARTERY STENTING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; CORONARY ARTERY BYPASS; CORONARY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEW YORK; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84875306253     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.11.073     Document Type: Article

References (19)

1. P.W. Serruys, M.-C. Morice, A.P. Kappetein Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
2. F.W. Mohr, M. Suttorp, W.J. van Boven Four-year follow-up of the SYNTAX trial: Optimal revascularization strategy in patients with three-vessel disease (Abstract) J Am Coll Cardiol 58 2011 B8
3. J. Booth, T. Clayton, J. Pepper Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease - Six-year follow-up from the Stent or Surgery trial (SoS) Circulation 118 2008 381 388
4. W. Hueb, N. Lopes, B.J. Gersh Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II) A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease Circulation 122 2010 949 957
5. A.E. Rodriguez, J. Baldi, C. Fernández Pereira Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II) J Am Coll Cardiol 46 2005 582 588
6. P.W. Serruys, A.T.L. Ong, L.A. van Herwerden Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial J Am Coll Cardiol 46 2005 575 581
7. E.L. Hannan, M.J. Racz, G. Walford Long-term outcomes of coronary-artery bypass grafting versus stent implantation N Engl J Med 352 2005 2174 2183
8. D.J. Malenka, B.J. Leavitt, M.J. Hearne Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England Circulation 112 suppl 9 2005 I371 I376
9. T.L. Bair, J.B. Muhlestein, H.T. May Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry Circulation 116 suppl 11 2007 I226 I231
10. A. Javaid, D.H. Steinberg, A.N. Buch Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting Stents for patients with multivessel coronary artery disease Circulation 116 suppl 11 2007 I200 I206
11. C. Wu, S. Zhao, A.S. Wechsler Long-term mortality of coronary artery bypass grafting and bare-metal stenting Ann Thorac Surg 92 2011 2132 2138
12. E.L. Hannan, C. Wu, G. Walford Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease N Engl J Med 358 2008 331 341
13. Y. Li, Z. Zheng, B. Xu Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution Circulation 119 2009 2040 2050
14. P.W. Serruys, Y. Onuma, S. Garg 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions J Am Coll Cardiol 55 2010 1093 1101
15. W.S. Weintraub, M.V. Grau-Sepulveda, J.M. Weiss Comparative effectiveness of revascularization strategies N Engl J Med 366 2012 1467 1476
16. D.Y. Lin, L.J. Wei The robust inference for the Cox proportional hazards model J Am Stat Assoc 84 1989 1074 1078
17. A.P. Kappetein, T.E. Feldman, M.J. Mack Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial Eur Heart J 32 2011 2125 2134
18. T.D. Yan, R. Padang, C. Poh Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies J Thorac Cardiovasc Surg 141 2011 1134 1144
19. G. Sianos, M.A. Morel, A.P. Kappetein The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease EuroIntervention 1 2005 219 227